These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 38794212)
21. The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Baumann P; Ulrich S; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Hiemke C; Dialogues Clin Neurosci; 2005; 7(3):231-47. PubMed ID: 16156382 [TBL] [Abstract][Full Text] [Related]
22. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644 [TBL] [Abstract][Full Text] [Related]
23. Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape. Preijers T; Muller AE; Abdulla A; de Winter BCM; Koch BCP; Sassen SDT Drugs; 2024 Oct; 84(10):1167-1178. PubMed ID: 39240531 [TBL] [Abstract][Full Text] [Related]
24. Utilization of antipsychotic therapeutic drug monitoring at a state psychiatric hospital. Wong KR; Nelson LA; Elliott ESR; Liu Y; Sommi RW; Winans EA Ment Health Clin; 2016 Jan; 6(1):1-7. PubMed ID: 29955441 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
26. Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use? Alffenaar JC; Akkerman OW; Kim HY; Tiberi S; Migliori GB Int J Infect Dis; 2020 Mar; 92S():S5-S9. PubMed ID: 31996324 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years. Voulgaridou G; Paraskeva T; Ragia G; Atzemian N; Portokallidou K; Kolios G; Arvanitidis K; Manolopoulos VG Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765152 [TBL] [Abstract][Full Text] [Related]
29. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology. Erku D; Schneider J; Scuffham P Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring. Albader F; Golovics PA; Gonczi L; Bessissow T; Afif W; Lakatos PL World J Gastroenterol; 2021 Oct; 27(37):6231-6247. PubMed ID: 34712029 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic monitoring of anti-seizure medications in low- and middle-income countries: a systematic review. Odhiambo M; Kariuki SM; Newton CR Wellcome Open Res; 2021; 6():92. PubMed ID: 37457427 [TBL] [Abstract][Full Text] [Related]
32. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine. Gaspar VP; Ibrahim S; Zahedi RP; Borchers CH J Mass Spectrom; 2021 Nov; 56(11):e4788. PubMed ID: 34738286 [TBL] [Abstract][Full Text] [Related]
34. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
35. Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases. Papamichael K; Stocco G; Ruiz Del Agua A Ther Drug Monit; 2023 Oct; 45(5):579-590. PubMed ID: 37012629 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice. Burke MJ; Preskorn SH Clin Pharmacokinet; 1999 Aug; 37(2):147-65. PubMed ID: 10496302 [TBL] [Abstract][Full Text] [Related]
37. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts. Wu CY; Li GT; Chu CC; Guo HL; Fang WR; Li T; Wang YR; Xu J; Hu YH; Zhou L; Chen F Arch Toxicol; 2023 Feb; 97(2):377-392. PubMed ID: 36418572 [TBL] [Abstract][Full Text] [Related]
38. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. Solmi M; Fornaro M; Ostinelli EG; Zangani C; Croatto G; Monaco F; Krinitski D; Fusar-Poli P; Correll CU World Psychiatry; 2020 Jun; 19(2):214-232. PubMed ID: 32394557 [TBL] [Abstract][Full Text] [Related]
39. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring. Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695 [TBL] [Abstract][Full Text] [Related]
40. Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies. Resztak M; Sobiak J; Czyrski A Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]